Penumbra, Inc. (PEN): Price and Financial Metrics

PEN POWR Grades

• PEN scores best on the Growth dimension, with a Growth rank ahead of 99.65% of US stocks.
• The strongest trend for PEN is in Growth, which has been heading up over the past 177 days.
• PEN's current lowest rank is in the Momentum metric (where it is better than 6.97% of US stocks).

PEN Stock Summary

• PEN's current price/earnings ratio is 326.64, which is higher than 98.26% of US stocks with positive earnings.
• Price to trailing twelve month operating cash flow for PEN is currently 509.98, higher than 99.58% of US stocks with positive operating cash flow.
• Over the past twelve months, PEN has reported earnings growth of -199.29%, putting it ahead of just 7.2% of US stocks in our set.
• Stocks that are quantitatively similar to PEN, based on their financial statements, market capitalization, and price volatility, are MNTX, FLYW, LTRX, CYRX, and ISSC.
• PEN's SEC filings can be seen here. And to visit PENUMBRA INC's official web site, go to www.penumbrainc.com.

PEN Valuation Summary

• In comparison to the median Healthcare stock, PEN's price/earnings ratio is 1123.22% higher, now standing at 326.6.
• PEN's price/sales ratio has moved up 1.8 over the prior 98 months.

Below are key valuation metrics over time for PEN.

PEN Growth Metrics

The 4 year revenue growth rate now stands at 99.67%.
• Its 4 year price growth rate is now at 120.95%.
• Its year over year cash and equivalents growth rate is now at 22.52%.

Over the past 52 months, PEN's revenue has gone up $426,937,000.

The table below shows PEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	847.133	-55.661	-2.002
2022-09-30	829.928	-66.268	-30.512
2022-06-30	806.367	-16.909	-19.391
2022-03-31	782.281	19.356	-6.473
2021-12-31	747.59	9.502	5.284
2021-09-30	710.477	16.689	33.565

PEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PEN has a Quality Grade of C, ranking ahead of 49.95% of graded US stocks.
• PEN's asset turnover comes in at 0.794 -- ranking 38th of 186 Medical Equipment stocks.
• IVC, NTUS, and MLSS are the stocks whose asset turnover ratios are most correlated with PEN.

The table below shows PEN's key quality metrics over time.